← Back to catalogue

Trinity Biotech

FDA UDI

Class I (US FDA UDI)

by Primus Corp.

Identity

Trade Name
Trinity Biotech FDA UDI
Generic Name
Glycated haemoglobin (HbA1c) IVD, control FDA UDI
Device Name
Hemoglobin A1c assay, Tri-stat Liquid Controls Kit FDA UDI
Model / Reference
Tri-stat Liquid Controls Kit FDA UDI
Description
Hemoglobin A1c assay, Tri-stat Liquid Controls Kit FDA UDI

Identifiers

Catalog Number
03-06-0011 FDA UDI
Primary DI / UDI-DI
05391516748216 FDA UDI
FDA Product Code
JJX FDA UDI
GMDN Term
Glycated haemoglobin (HbA1c) IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

Yes

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Glycated haemoglobin (HbA1c) IVD, control

Trinity Biotech by Primus Corp. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Glycated haemoglobin (HbA1c) IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Primus Corp.

Sources (1)

  • FDA UDI d014d69e-2291-4754-89c9-3f8fc041a7fd 36 fields · synced Jun 8, 2026